| mRNA |
GSK1120212 |
CTRPv2 |
pan-cancer |
AAC |
-0.24 |
2e-05 |
| mRNA |
selumetinib:navitoclax (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.17 |
2e-05 |
| mRNA |
BRD9876 |
CTRPv2 |
pan-cancer |
AAC |
0.18 |
2e-05 |
| mRNA |
isonicotinohydroxamic acid |
CTRPv2 |
pan-cancer |
AAC |
0.22 |
3e-05 |
| mRNA |
GSK-650394 |
GDSC1000 |
pan-cancer |
AAC |
-0.17 |
3e-05 |
| mRNA |
AZ628 |
GDSC1000 |
pan-cancer |
AAC |
-0.22 |
4e-05 |
| mRNA |
tivozanib |
GDSC1000 |
pan-cancer |
AAC |
-0.16 |
4e-05 |
| mRNA |
MK-2206 |
CTRPv2 |
pan-cancer |
AAC |
0.17 |
5e-05 |
| mRNA |
GSK2636771 |
CTRPv2 |
pan-cancer |
AAC |
0.19 |
5e-05 |
| mRNA |
AZD6244 |
CTRPv2 |
pan-cancer |
AAC |
-0.16 |
5e-05 |